Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.67 |
| ▸ | CTSD | P07339 | 1/20 | 0.67 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28653295 | 0.88 | ALDH1A1 (0.46) | ALDH1A1TDP1CTSDGAAALOX12 | |
| SCHEMBL904596 | 0.83 | ALDH1A1 (0.72) | ALDH1A1TDP1NOX1ALOX12CYP1A2 | |
| SCHEMBL19737269 | 0.82 | ALDH1A1 (1.00) | ALDH1A1TDP1CTSDGAAALOX12 | |
| Hydrazobenzene SCHEMBL51179 | 0.82 | ALDH1A1 (1.00) | ALDH1A1TDP1CTSDGAAALOX12 | |
| SCHEMBL6101646 | 0.79 | NPC1 (0.55) | ALDH1A1TDP1CTSDGAAALOX12 | |
| SCHEMBL5113271 | 0.77 | MEN1 (0.59) | ALDH1A1TDP1CTSDGAAMAPT | |
| SCHEMBL21563477 | 0.77 | ALDH1A1 (0.62) | ALDH1A1TDP1NOX1ALOX12CYP1A2 | |
| SCHEMBL22620524 | 0.77 | ALDH1A1 (0.81) | ALDH1A1TDP1CTSDGAAALOX12 | |
| SCHEMBL14819026 | 0.77 | ALDH1A1 (0.81) | ALDH1A1TDP1CTSDGAAALOX12 | |
| SCHEMBL3989832 | 0.76 | KMT2A (0.46) | GAAALOX12CYP1A2MAPTCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080182870-A1 | PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS | GILEAD SCIENCES, INC. (US) | 2008-07-31 | — | — | US | claimed |
| CN-118930453-A | Method for synthesizing hydroazobenzene compound by reducing azobenzene with triethylamine under catalysis of visible light | 云南民族大学 | 2024-11-12 | — | — | CN | disclosed |
| CN-115368268-A | Method for efficiently preparing azo compound and application thereof | 大连理工大学 | 2022-11-22 | — | — | CN | disclosed |
| CN-113773234-A | Method for oxidizing hydrazine compound into azo compound | 台州学院 | 2021-12-10 | — | — | CN | disclosed |
| EP-2880030-A1 | BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF | Sunshine Lake Pharma Co., Ltd. (CN) | 2015-06-10 | — | — | EP | disclosed |
| WO-2014019344-A1 | BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2014-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080182870-A1 | PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS | PNPO, DPYD, PNP | ALDH1A1 1142/4885TDP1 1584/4885CTSD 2802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.